Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway

Deng,Gang; Ju,Xiang; Meng,Qi; Yu,Zhi‑Jian; Ma,Li‑Bin

doi:10.3892/mmr.2015.3923

Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway

Authors:
- Gang Deng
- Xiang Ju
- Qi Meng
- Zhi‑Jian Yu
- Li‑Bin Ma
View Affiliations

Affiliations: Division of Urology, The First People's Hospital of Hangzhou, Hangzhou, Zhejiang 310006, P.R. China
Published online on: June 12, 2015 https://doi.org/10.3892/mmr.2015.3923
Pages: 4427-4433

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the anticarcinogenic effects of emodin on the Notch signaling pathway and vascular endothelial growth factor (VEGF) in the PC3 androgen-independent prostate cancer cell line in vitro. The cell viability was assessed using an 3‑(4,5)‑dimethylthiahiazo(‑z‑y1)‑3,5‑di‑phenytetrazolium bromide assay. Cell apoptosis and cell cycle were detected using flow cytometry. Morphological alterations were observed using transmission electron microscopy. The mRNA and protein expression levels of Notch1, Jagged1, VEGF and bFGF were detected using reverse transcription‑quantitative polymerase chain reaction and western blotting, respectively. Laser scanning confocal microscope (LSCM) immunofluorescence analysis was performed to detect the levels of expression and the sub‑cellular localization of the Notch1 receptor protein. Growth of the PC3 cells was inhibited by emodin. Flow cytometry demonstrated that emodin induced apoptosis in the PC3 cells and arrested the cell cycle of the PC3 cells at the G2/M phase. The mRNA and protein expression of Notch1 in the PC3 cells was markedly increased, whereas the mRNA and protein expression levels of Jagged1, VEGF and bFGF were significantly decreased following exposure to emodin for 24 h. The LSCM assay revealed that the Notch1 was not only localized in the membrane and cytoplasm, but was also present in the nucleolus of the PC3 cells, and the expression of Notch1 in the nuclei gradually increased following treatment with emodin. These results demonstrated that emodin suppressed the growth of androgen‑independent prostate cancer cell lines and induced apoptosis and cell cycle arrest. The Notch signaling pathway was activated in the PC3 cells following exposure to emodin, which suggested that the Notch signaling pathway is involved in the prostate tumor‑suppressing mechanisms of emodin, the activation of which may depend on CBF1 protein in the nucleus by classic pathways. The antitumor function of emodin, attributed to the Notch signaling pathway, induced the downregulation of VEGF by suppressing tumorigenesis and angiogenesis, which indicated a novel mechanism underlying the emodin-mediated anti-prostate cancer effect.

View Figures

View References

1	McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52:6940–6944. 1992.PubMed/NCBI
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
3	Petrylak DP: Chemotherapy for advanced hormone refractory prostate cancer. Urology. 54(Suppl): 30–35. 1999. View Article : Google Scholar : PubMed/NCBI
4	Pisters LL: The challenge of locally advanced prostate cancer. Semin Oncol. 26:202–216. 1999.PubMed/NCBI
5	Richie JP: Anti-androgens and other hormonal therapies for prostate cancer. Urology. 54(Suppl): 15–18. 1999. View Article : Google Scholar : PubMed/NCBI
6	Yu CX, Zhang XQ, Kang LD, Zhang PJ, Chen WW, Liu WW, Liu QW and Zhang JY: Emodin induces apoptosis in human prostate cancer cell LNCaP. Asian J Androl. 10:625–634. 2008. View Article : Google Scholar : PubMed/NCBI
7	Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol. 100:72–79. 2005. View Article : Google Scholar : PubMed/NCBI
8	Lin SZ, Wei WT, Chen H, Chen KJ, Tong HF, Wang ZH, Ni ZL, Liu HB, Guo HC and Liu DL: Antitumor activity of emodin against pancreatic cancer depends on its dual role: Promotion of apoptosis and suppression of angiogenesis. PLoS One. 7:e421462012. View Article : Google Scholar : PubMed/NCBI
9	Su YT, Chang HL, Shyue SK and Hsu SL: Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol. 70:229–241. 2005. View Article : Google Scholar : PubMed/NCBI
10	Chen YC, Shen SC, Lee WR, Hsu FL, Lin HY, Ko CH and Tseng SW: Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem Pharmacol. 64:1713–1724. 2002. View Article : Google Scholar : PubMed/NCBI
11	Damodharan U, Ganesan R and Radhakrishnan UC: Expression of MMP2 and MMP9 (gelatinases A and B) in human colon cancer cells. Appl Biochem Biotechnol. 165:1245–1252. 2011. View Article : Google Scholar : PubMed/NCBI
12	Guo HC, Bu HQ, Luo J, Wei WT, Liu DL, Chen H, Tong HF, Wang ZH, Wu HY, Li HH, et al: Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis. Int J Oncol. 40:1849–1857. 2012.PubMed/NCBI
13	Cha TL, Qiu L, Chen CT, Wen Y and Hung MC: Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res. 65:2287–2295. 2005. View Article : Google Scholar : PubMed/NCBI
14	Shou J, Ross S, Koeppen H, de Sauvage FJ and Gao WQ: Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res. 61:7291–7297. 2001.PubMed/NCBI
15	Carvalho FL, Simons BW, Eberhart CG and Berman DM: Notch signaling in prostate cancer: A moving target. Prostate. 74:933–945. 2014. View Article : Google Scholar : PubMed/NCBI
16	Zhao Y, Yang LF, Ye M, Gu HH and Cao Y: Induction of apoptosis by epigallocatechin-3-gallate via mitochondrial signal transduction pathway. Prev Med. 39:1172–1179. 2004. View Article : Google Scholar : PubMed/NCBI
17	Schreiber E, Harshman K, Kemler I, Malipiero U, Schaffner W and Fontana A: Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 18:5495–5503. 1990. View Article : Google Scholar : PubMed/NCBI
18	Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, et al: Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med. 8:979–986. 2002. View Article : Google Scholar : PubMed/NCBI
19	Tsai T and Chen C: Ultraviolet spectrum identification of emodin in rabbit plasma by HPLC and its pharmacokinetics application. Asia Pac J Pharmacol. 1:53–56. 1992.
20	Koyama M, Kelly TR and Watanabe KA: Novel type of potential anticancer agents derived from chrysophanol and emodin. Some structure-activity relationship studies. J Med Chem. 31:283–284. 1988. View Article : Google Scholar : PubMed/NCBI
21	Huang HC, Chu SH and Chao PD: Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol. 198:211–213. 1991. View Article : Google Scholar : PubMed/NCBI
22	Zhou XM and Chen QH: Biochemical study of Chinese rhubarb. XXII. Inhibitory effect of anthraquinone derivatives on Na+-K+-ATPase of the rabbit renal medulla and their diuretic action. Yao Xue Xue Bao. 23:17–20. 1988.In Chinese. PubMed/NCBI
23	Lee HZ: Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. Br J Pharmacol. 134:11–20. 2001. View Article : Google Scholar : PubMed/NCBI
24	Jing X, Ueki N, Cheng J, Imanishi H and Hada T: Induction of apoptosis in hepatocellular carcinoma cell lines by emodin. Jpn J Cancer Res. 93:874–882. 2002. View Article : Google Scholar
25	Shieh DE, Chen YY, Yen MH, Chiang LC and Lin CC: Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Life Sci. 74:2279–2290. 2004. View Article : Google Scholar : PubMed/NCBI
26	Huang XZ, Wang J, Huang C, Chen YY, Shi GY, Hu QS and Yi J: Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol Ther. 7:468–475. 2008. View Article : Google Scholar : PubMed/NCBI
27	Kwak HJ, Park MJ, Park CM, Moon SI, Yoo DH, Lee HC, Lee SH, Kim MS, Lee HW, Shin WS, et al: Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation. Int J Cancer. 118:2711–2720. 2006. View Article : Google Scholar : PubMed/NCBI
28	Zhou ZD, Kumari U, Xiao ZC and Tan EK: Notch as a molecular switch in neural stem cells. IUBMB Life. 62:618–623. 2010. View Article : Google Scholar : PubMed/NCBI
29	Lai EC: Notch signaling: Control of cell communication and cell fate. Development. 131:965–973. 2004. View Article : Google Scholar : PubMed/NCBI
30	Ang HL and Tergaonkar V: Notch and NFkappaB signaling pathways: Do they collaborate in normal vertebrate brain development and function? BioEssays. 29:1039–1047. 2007. View Article : Google Scholar : PubMed/NCBI
31	Chau MD, Tuft R, Fogarty K and Bao ZZ: Notch signaling plays a key role in cardiac cell differentiation. Mech Dev. 123:626–640. 2006. View Article : Google Scholar : PubMed/NCBI
32	Wang XD, Leow CC, Zha J, Tang Z, Modrusan Z, Radtke F, Aguet M, de Sauvage FJ and Gao WQ: Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol. 290:66–80. 2006. View Article : Google Scholar
33	Yao J, Duan L, Fan M, Yuan J and Wu X: Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: Involvement of nuclear factor kappa B inhibition. Int J Gynecol Cancer. 17:502–510. 2007. View Article : Google Scholar : PubMed/NCBI
34	Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB and Mignatti P: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol. 141:1659–1673. 1998. View Article : Google Scholar : PubMed/NCBI
35	Siekmann AF, Covassin L and Lawson ND: Modulation of VEGF signalling output by the Notch pathway. BioEssays. 30:303–313. 2008. View Article : Google Scholar : PubMed/NCBI